SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Supriya Lifescience Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
543434 INE07RO01027 93.5818038 SUPRIYA 0.16 3,030.98 25.17 14.96 2
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales140.07140.10132.02
Other Operating Income0.000.000.00
Other Income 3.072.472.92
Total Income143.14142.56134.94
Total Expenditure 98.59108.3487.79
PBIDT44.5534.2247.15
Interest 0.490.460.56
PBDT44.0633.7646.59
Depreciation3.963.983.96
Tax9.668.549.96
Fringe Benefit Tax0.000.000.00
Deferred Tax0.66-2.644.16
Reported Profit After Tax29.7923.8828.51
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item29.7923.8828.51
    
EPS (Unit Curr.)3.702.973.54
EPS (Adj) (Unit Curr.)3.702.973.54
Calculated EPS (Unit Curr.)3.702.973.54
Calculated EPS (Adj) (Unit Curr.)3.702.973.54
Calculated EPS (Ann.) (Unit Curr.)14.8011.8714.17
Calculated EPS (Adj) (Ann.) (Unit Curr.)14.8011.8714.17
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity16.1016.1016.10
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)31.8124.4335.71
PBDTM(%)31.4624.1035.29
PATM(%)21.2717.0421.60